Splenic Hilar Nodes in Splenic Flexure Cancer

University of Rome Tor Vergata20 enrolled

Overview

Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Colon Cancer Metastases, Lymphatic

Interventions

Review of records and follow upOTHER

Follow up to identify patients who developed splenic hilar nodal metastases

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All splenic flexure cancer patients Exclusion Criteria: * No consent to data utilization

Locations (1)

Policlinico Tor Vergata

Roma, RM, Italy

Outcomes

Primary Outcomes

Splenic hilum nodal metastases

Time frame: 5 years

Central Contacts

Bruno Sensi, MD

CONTACT

3385352902 brunosensi@outlook.it

Giuseppe S Sica, MD, PhD

CONTACT

3385333659 sigisica@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.